Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2018

Open Access 01-12-2018 | Research article

Comparative efficacy of Chinese herbal injections for treating acute cerebral infarction: a network meta-analysis of randomized controlled trials

Authors: Shi Liu, Jia-Rui Wu, Dan Zhang, Kai-Huan Wang, Bing Zhang, Xiao-Meng Zhang, Di Tan, Xiao-Jiao Duan, Ying-Ying Cui, Xin-Kui Liu

Published in: BMC Complementary Medicine and Therapies | Issue 1/2018

Login to get access

Abstract

Background

Chinese herbal injections (CHIs) are prepared by extracting and purifying effective substances from herbs (or decoction pieces) using modern scientific techniques and methods. CHIs combined with aspirin + anticoagulants + dehydrant + neuroprotectant (AADN) are believed to be effective for the treatment of acute cerebral infarction (ACI). However, no randomized controlled trial (RCT) has been performed to directly compare the efficacies of different regimens of CHIs. Therefore, we performed a systematic review and network meta-analysis (NMA) to compare the efficacies of different regimens of CHIs for ACI.

Methods

We conducted an overall and systematic retrieval from literature databases of RCTs focused on the use of CHIs to treat ACI up to June 2016. We used the Cochrane Handbook version 5.1.0 and CONSORT statement to assess the risk of bias. The data were analyzed using STATA 13.0 and WinBUGS 1.4.3 software.

Results

Overall, 64 studies with 6225 participants involving 15 CHIs were included in the NMA. In terms of the markedly effective rate, Danhong (DH) + AADN had the highest likelihood of being the best treatment. In terms of the improvement of neurological impairment, Shuxuening (SXN) + AADN had the highest likelihood of being the best treatment. Considering two outcomes, injections of SXN, Yinxingdamo (YXDM), DH, Shuxuetong (SXT), HongHuaHuangSeSu (HHHSS), DengZhanXiXin (DZXX) and Shenxiong glucose (SX) plus AADN were the optimum treatment regimens for ACI, especially SXN + AADN and YXDM + AADN.

Conclusions

Based on the NMA, SXN, YXDM, DH, SXT, HHHSS, DZXX and SX plus AADN showed the highest probability of being the best treatment regimens. Due to the limitations of the present study, our findings should be verified by well-designed RCTs.
Appendix
Available only for authorised users
Literature
1.
Luo JN. New progress on treating acute cerebral infarction. Pract J card Cereb Pneumal. Vasc Dis. 2010;18:1546–7.
2.
Hui Z, Sha DJ, Wang SL, et al. Panaxatriol saponins promotes angiogenesis and enhances cerebral perfusion after ischemic stroke in rats. BMC Complement Altern Med. 2017;17:70.PubMedPubMedCentralCrossRef
3.
Wang K, Zhang D, Wu J, et al. A comparative study of Danhong injection and Salvia miltiorrhiza injection in the treatment of cerebral infarction: a systematic review and meta-analysis. Med. 2017;96:e7079.CrossRef
4.
Inoue T, Kobayashi M, Uetsuka Y, Uchiyama S. Pharmacoeconomic analysis of cilostazol for the secondary prevention of cerebral infarction. Circ J. 2006;70:453–8.PubMedCrossRef
5.
Sun W, Ou Q, Zhang Z, et al. Chinese acute ischemic stroke treatment outcome registry (CASTOR): protocol for a prospective registry study on patterns of real-world treatment of acute ischemic stroke in China. BMC Complement Altern Med. 2017;17:357.PubMedPubMedCentralCrossRef
6.
Wei J, Yang W, Yin S, et al. The quality of reporting of randomized controlled trials of electroacupuncture for stroke. BMC Complement Altern Med. 2016;16:512.PubMedPubMedCentralCrossRef
7.
Wang KH, Wu JR, Liu S, Zhang D, Duan XJ, Zhang B. Meta-analysis on randomized controlled trials of xingnaojing injection for treating acute cerebral infarction. Chin J Pharmacoepidemiol. 2017;15:471–6.
8.
You YN, Cho MR, Kim JH, et al. Assessing the quality of reports about randomized controlled trials of scalp acupuncture combined with another treatment for stroke. BMC Complement Altern Med. 2017;17:452.PubMedPubMedCentralCrossRef
9.
Sun K, Fan J, Han J. Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage. Acta Pharm Sin B. 2015;5:8–24.PubMedPubMedCentralCrossRef
10.
Cao W, Liu W. Wu T, Zhong D, Liu G. Dengzhanhua preparations for acute cerebral infarction. Cochrane Database Syst Rev. 2008;63:CD005568.
11.
Liao P, Wang L, Guo L, Zeng R, Huang J, Zhang M. Danhong injection (a traditional Chinese patent medicine) for acute myocardial infarction: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2015;2015:646530.PubMedPubMedCentral
12.
Xie CL, Wang WW, Xue XD, Zhang SF, Gan J, Liu ZG. A systematic review and meta-analysis of Ginsenoside-Rg1 (G-Rg1) in experimental ischemic stroke. Sci Rep. 2015;5:7790.PubMedPubMedCentralCrossRef
13.
Li B, Wang Y, Lu J, Liu J, Yuan Y, Yu Y, et al. Evaluating the effects of Danhong injection in treatment of acute ischemic stroke: study protocol for a multicenter randomized controlled trial. Trials. 2015;16:561.PubMedPubMedCentralCrossRef
14.
Yu YC, Wu SZ, Hou Q. Clinical study on Xueshuantong combined with aspirinon in treatment of senium acute cerebral infarction. Drugs & Clinic. 2014;7:782–5.
15.
CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997;349:1641–9.CrossRef
16.
The International Stroke Trial (IST). A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International stroke trial collaborative group. Lancet. 1997;349:1569–81.CrossRef
17.
Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis. 2003;15:222–9.CrossRef
18.
Gu XL, Ding XS, Di Q. Clinical study on edaravone injection in treatment of acute cerebral infarction. Chinese J New Drugs Clin Remedies. 2005;24:113–6.
19.
Zhang M, Xu LJ, Deng LY. Efficacy and safety of Edaravone injection in the treatment of acute cerebral infarction: a randomized, double blind, multicenter study. Chinese J New Drugs Clin Remedies. 2007;26:105–8.
20.
Davalos A, Castillo J, Alvarez-Sabin J, Secades JJ, Mercadal J, López S, et al. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke. 2002;33:2850–7.PubMedCrossRef
21.
National Pharmacopoeia Committee. Chinese pharmacopoeia, part 1, Appendix 13. Beijing, China: Chemical Industry Press; 2005.
22.
Xie YY, Xiao X, Luo J-M, Fu C, Wang Q-W, Wang Y-M, et al. Integrating qualitative and quantitative characterization of traditional Chinese medicine injection by high-performance liquid chromatography with diode array detection and tandem mass spectrometry. J Sep Sci. 2014;37:1438–47.PubMedCrossRef
23.
Liu J, Liu F, Li PH. Analysis of the adverse reaction of traditional Chinese medicine injections activating blood stasis. China Pharmacy. 2011;22:646–8.
24.
Tan D, Wu JR, Liu S, Zhang B. Meta-analysis of efficacy of shuxuening injection in the treatment of cerebral infarction. J Pharmacoepidemiol. 2016;8:492–8.
25.
Wang X, Wu JR, Zhang D, Wang KH, Zhang B. Meta-analysis of efficacy of xueshuantong injection in the treatment of acute cerebral infarction. J Pharmacoepidemiol. 2016;10:616–22.
26.
Wang KH, Wu JR, Zhang D, Liu S, Zhang XM, Zhang B. Meta-analysis of efficacy of mailuoning injection in the treatment of acute cerebral infarction. J Pharmacoepidemiol. 2016;9:544–8. 590
27.
Duan XJ, Wu JR, Liu S, Zhang D, Fang J, Zhang B. Meta-analysis of efficacy of danshenchuanxiongqin injection in the treatment of acute cerebral infarction. J Pharmacoepidemiol. 2017;1:27–32.
28.
Liu X-T, Ren P-W, Peng L, Kang D-Y, Zhang T-L, Wen S, et al. Effectiveness and safety of ShenXiong glucose injection for acute ischemic stroke: a systematic review and GRADE approach. BMC Complement Altern Med. 2016;16:68.PubMedPubMedCentralCrossRef
29.
Wu J, Zhang XM, Zhang B. Qingkailing injection for the treatment of acute stroke: a systematic review and meta-analysis. J Tradit Chin Med. 2014;34:131–9.PubMedCrossRef
30.
Zhang X, Wu J, Zhang B. Xuesaitong injection as one adjuvant treatment of acute cerebral infarction: a systematic review and meta-analysis. BMC Complement Altern Med. 2015;15:36.PubMedPubMedCentralCrossRef
31.
Peng W, Yang J, Wang Y, Wang W, Xu J, Wang L, et al. Systematic review and meta-analysis of randomized controlled trials of Xingnaojing treatment for stroke. Evid Based Complement Altern Med. 2014;2014:210851.
32.
Wu B, Liu M, Liu H, Li W, Tan S, Zhang S, et al. Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke. 2007;38:1973–9.PubMedCrossRef
33.
Jinatongthai P, Kongwatcharapong J, Foo CY, Phrommintikul A, et al. Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis. Lancet. 2017;390:747–59.PubMedCrossRef
34.
Sun F, Chai SB, Li LS, et al. Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis. J Diabetes Res. 2015;2015:157201.PubMedPubMedCentralCrossRef
35.
Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23:3105–24.PubMedCrossRef
36.
The fourth session of the National Cerebrovascular Conference. The norm of clinical neurologic deficit score. Chin J Neurol. 1996;29:381–3.
37.
38.
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63:e1–37.PubMedCrossRef
39.
Salanti G, Ades AE, Ioannidis JPA. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64:163–71.PubMedCrossRef
40.
Riley RD, Higgins JPT, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549.PubMedCrossRef
41.
42.
43.
Yu YM, Ran ZJ. Clinical study on 58 cases acute cerebral infarction treated by Danhong injection. Pract J Card Cereb Pneum Vasc Dis. 2009;17:477–8.
44.
Yu Y. Clinical study on Xueshuantong in treatment of acute cerebral infarction. Chinese Foreign Med Res. 2015;13:32–3.
45.
Zhang ZJ, Cao CY. Clinical study on Shenxiong glucose injection in treatment of acute cerebral infarction and its effect on plasma endothelin. J Guangdong Med Coll. 2008;26:408–9.
46.
Zheng XD. Curative effect with dipyridamole plus aspirin therapy in acute cerebral infarction. J Mod Clin Med. 2007;33:171–3.
47.
Zhou SJ. Study on Shenxiong glucose injection in treatment of acute cerebral infarction. Mod. Prev Med. 2011;38:2656–9.
48.
Zhou SF, Huo Y. Study on Ginkgo dipyridolum injection combined with aspirinon in treatment of acute cerebral infarction. J Mudanjiang Med Univ. 2009;20:56–8.
49.
Zhou SH. Effect of Shu Xue Ning injection on serum IL - 6 and its efficacy in patients with acute cerebral infarction. Zhejiang J Tradit Chin Med. 2013;48:923.
50.
Xu XY. Study on Ginkgo dipyridolum injection in treatment of acute cerebral infarction. In: Shandong province, the third integrated traditional Chinese medicine and western medicine academic symposium. Jinan; 2011. p. 268–270.
51.
Xie S, Cao C. Effect of Shuxuening injection in patients with acute cerebral infarction. J Med Theory Pract. 2011;24:1891–2.
52.
Xie YG, Zhou JH. Observation of effect of Suxuetong injection on acute cerebral infarction. China Trop Med. 2010;10:352–92.
53.
Xu LL, Meng QY, Tian L, Liu XH, Liu T. Curative effection of tetramethylpyrazine on acute cerebral infarction. J Pract Tradit Chinese Intern Med. 2011;25:57–8.
54.
Xu XQ. The observation of aplication of Ginkgo leaf extract and diphyridamole injection in the treatment of acute cerebral infarction. Chinese J Exp Tradit Med Formulae. 2012;18:211–3.
55.
Yang HJ. Effect of Xuetong injection in patients with acute cerebral infarction. J Pract Med Tech. 2007;14:2157.
56.
Yang YF. Study on Danhong injection combined with aspirinon in treatment of acute cerebral infarction. J Psychol Doctor. 2012;3:30.
57.
Yao QY, Gong SJ. Effect of Shuxuetong injection in patients with acute cerebral infarction. Mod J Integr Tradit Chinese Western Med. 2010;19:3389–90.
58.
Yao J, Lu XR. The observation of aplication of Ginkgo leaf extract and diphyridamole injection in the treatment of acute cerebral infarction. Clin Med. 2010;30:44–5.
59.
Xie RP. Clinical study on Shuxuening in treatment of acute cerebral infarction. Proc Clin Med. 2010;19:758–9.
60.
Tan SY, Tan ZL. Clinical study of Danhong injection in the treatment of cerebral infarction caused by branch atheromatous disease. J Shenyang Med Coll. 2016;18:18–20.
61.
Wang WP. Study on Ginkgo dipyridolum injection combined with Fufangdanshen injection in treatment of acute cerebral infarction. Shenzhen J Integr Tradit Chinese and Western Med. 2015;25:21–2.
62.
Ren HM. The observation of aplication of Shenxiong injection in the treatment of acute cerebral infarction. China Healthcare Innov. 2009;4:27.
63.
Sun HJ, Zheng MH, Liang TS. Effects of Chuangxiongqin injection on serum sCD40L and the level of hs-CRP in patients with angina pectoris. J Shanghai Univ Tradit Chin Med. 2013;27:39–41.
64.
Tang JP, Jiang P, Yang XY. Clinical efficacy and safety of safflower yellow pigment injection in the treatment of acute cerebral infarction. J Mod Med Health. 2013;29:2524–5.
65.
Tang FY, Zhang GW. Clinical study on 36 cases acute cerebral infarction treated by breviscapine injection. Chinese J Pract Med. 2009;36:51–2.
66.
Tang XJ. Study on Ginkgo damole injection combined with aspirinon in treatment of acute cerebral infarction. Hebei Med J. 2013;35:1188–9.
67.
Wang L. Clinical study on 48 cases acute cerebral infarction treated by Shenxiong glucose injection. China Foreign Med Treat. 2010;29:116.
68.
Wang YL, Zou XH, Dang LH. Expression of TNF-a and IL-6 in patients with acute cerebral infarction after clinical intervention of Shuxuetong injection and clinical significance. J Yunnan UnivTradit Chin Med. 2013;36:70–2.
69.
Lan Y, Xiao JX, Zheng TY, ZX L. Effect of salvia ligustrazin injection on lysophospholipids acid, P selection and its efficacy in patients with acute cerebral infarction. Mod J Integr Tradit Chinese Western Med. 2015;24:840–2.
70.
Li M, Li Q, Zhang M, Zhang XL, Hu Q, Pang Y. Effect of Dan Hong injection on serum S100B protein and neuron specific alcohol in patients with acute cerebral infarction. Herald Med. 2014;33:1596–9.
71.
Liu YP, Wang ZG, Wu H. Effect of Dan Hong injection on C-reactive protein and its efficacy in patients with acute cerebral infarction. Pract J Card Cereb Pneum Vasc Dis. 2010;18:1433–4.
72.
Ma J, Yu NW, Ren ZW, Chen M, Wu HH. Effect of breviscapine on serum NSE,Ang-2 and IL-6 levels and its efficacy in patients with acute cerebral infarction. Chinese J Biochem Pharm. 2010;35:110–2.
73.
Ma J, Yu NW, Wu HH, Chen M, Ren ZW, Zhao DD. Effect of Danhong injection on nerve function and hemorheology for patients with acute ischemic stroke. Chinese J Exp Tradit Med Formulae. 2015;21:204–7.
74.
Chen H. Clinical study on 67 cases acute cerebral infarction treated by Shuxuetong injection. Asia-Pacific Tradit Med. 2015;11:137–8.
75.
Luan T. The clinical effects of Xuesaitong injection in the treatment of acute cerebral infarction. Guide China Med. 2014;12:42–3.
76.
Huang ML. Clinical study on 150 cases acute cerebral infarction treated by Xueshuangtong injection. Mod Diagn Treat. 2012;23:2254–5.
77.
Li X, Zheng WW, Gao YB. Effect of carthamin yellow injection on NT-proBNP and TXB_2 for patients with acute ischemic stroke. Chinese J Integr Med Cardio/Cerebrovascular Dis. 2015;13:1900–2.
78.
Ma ZL, Wu BX, Cheng DM, Zhang XL, Hu Y. Clinic observation of the curative effect of safflor yellow in the treatment of acute cerebral infarction. Chinese J Pract Nerv Dis. 2011;14:30–1.
79.
Zhang Y, Hou J, Hu Y, Mu ZB, HY M. Study on Danshen Chuanxiongqin injection combined with edaravone in treatment of acute cerebral infarction. Chinese J Integr Med Cardio/Cerebrovascular Dis. 2012;10:168–9.
80.
Liu M. Study on Danshen Chuanxiongqin injection combined with edaravone in treatment of acute cerebral infarction. Mod J Integr Tradit Chinese Western Med. 2014;23:2105–7.
81.
Chen YC. Clinic observation of the curative effect of Ginkgo damole injection in the treatment of acute cerebral infarction. Chinese Foreign Med Res. 2011;9:45–6.
82.
Yang RF. Clinical research of edaravone combined with Shuxuetong in treating acute cerebral infarction. China J Chinese Med. 2013;28:1228–9.
83.
Lin YF, Wang ML, Huang ZQ, Yan P, Su Y. Clinical research of combined Ginkgo damole injection with aspirin in treating acute cerebral infarction. Proc Clin Med. 2008;17:761–2.
84.
Peng T, Pang YL. Clinic observation of the curative effect of Shuxuetong injection in the treatment of acute cerebral infarction. Pract J Card Cereb Pneum Vasc Dis. 2006;14:388.
85.
Li XH. Clinic observation of the curative effect of Shuxuening injection in the treatment of acute cerebral infarction. Asia-Pacific Tradit Med. 2011;7:129–30.
86.
Liu L, Yang XS, Chen W, Liu ZT. Clinic observation of the curative effect of Danhong injection in the treatment of acute cerebral infarction. Clin J Tradit Chin Med. 2014;26:166–7.
87.
Zhang YH, Liu WJ, Ding S. The clinical research of Danhong combinded with low molecular heparin calcium to treat the acute cerebral infarction. Pract J Card Cereb Pneum Vasc Dis. 2010;18:3–5.
88.
Fan J. Clinic observation of the curative effect of Ginkgo damole injection in the treatment of acute cerebral infarction. China Pharm. 2006;15:54.
89.
Liu HY, Liu YM. Clinical study on 64 cases acute cerebral infarction treated by Xuesaitong injection. Jilin Med J. 2014;2014:4963–4.
90.
Li FQ. Clinical study on 64 cases acute cerebral infarction treated by Ginkgo damole injection. Chinese J Ethnomed Ethnopharmacy. 2010;19:106.
91.
Lian CL. Clinical observation on 46 cases of acute cerebral infarction treated with combination of traditional Chinese and western medicine. J Pract Tradit Chin Med. 2013;29:456.
92.
Chen S, Jiang KW, Lu HZ. Clinic observation of the curative effect of Xuesaitong injection in the treatment of acute cerebral infarction. J Pract Med. 2006;22:1405–6.
93.
Cao L. Clinic observation of the curative effect of Xueshuangtong injection in the treatment of acute cerebral infarction. Chinese J Ethnomed Ethnopharmacy. 2012;21:71.
94.
Liu Y. Effective observation on acute cerebral infarction treated by Shuxuetong injection. Chinese J Med Guide. 2009;11:1157–8.
95.
Luo XD, Wang P, Zeng XR. Xuesaitong injection plus routine therapy for acute cerebral infarction and the influence on plasma C-reactive protein. Pract J Clin Med. 2011;8:96–8.
96.
Liao MJ, Chen ZB. Clinical study on 30 cases acute cerebral infarction treated by safflower yellow injection. Med Inf. 2014;27:109–10.
97.
Shi JL, Cheng JL. The clinical research of Ginkgo-damole combinded with atorvastatin calcium to treat the acute cerebral infarction. Chinese J Pract Nerv Dis. 2010;13:52–3.
98.
Ni H. Clinical study on 59 cases of Shuxuening combined with sodium ozagrel to treat the acute cerebral infarction. Jilin Med J. 2010;30:3078–9.
99.
Li CP. Clinical study on 80 cases acute cerebral infarction treated by Shuxuening injection. J Shanxi Coll Tradit Chin Med. 2007;8:37–8.
100.
Zhou ZP, Yang GS, Wang AY. Effect of erigeron injection on MMP- 9 in patient with acute cerebral infarction. Mod Prev Med. 2011;38:2660–1.
101.
Chen C. Efficacy and safety of aspirin plus clopidogrel and Shuxuetong in treatment of patients with acute cerebral infarction. Eval Anal Drug-Use Hosp China. 2015;15:808–10.
102.
Chen JY, Wang DC, Luo SW. Clinical study on 54 cases of Shuxuetong plus aspirin and clopidogrel to treat the acute cerebral infarction. China Pharmaceuticals. 2012;21:53–4.
103.
Luo QY. Clinic observation of the curative effect of Ginkgo bilboa injection in the treatment of acute cerebral infarction. Youjiang Med J. 2007;35:133–4.
104.
Chen J, Li SJ. Clinical observation of Ginkgo-dipyidamolum injection in treatment of acute cerebral infarction. Neural Inj Funct Reconstr. 2007;7:291–3.
105.
Zhang XL, Zhang LL, Heng XL, Ma Y, Pang W. Effect of Mailuoning injection on blood rheology for patients with acute ischemic stroke. Nerv Dis Mental Health. 2015;5:216–7.
106.
Ni HQ, Wu L, Li JF, Chen J. Meta-analysis of comparative study on Ginkgo dipyridolum injection in the treatment of acute cerebral infarction. China Pharm. 2008;19:1655–8.
107.
Xi BC, Zhang C, Sun LL. Meta-analysis of comparative study on Shuxuening injection in the treatment of acute cerebral infarction. Pharm Care Res. 2012;12:354–7.CrossRef
108.
Zheng WK, Zhang L, Shang HC. Systematic review on Shuxuening injection in treating acute cerebral infarction. Chinese Licensed Pharmacist. 2012;9:33–41.
109.
Rodríguez M, Ringstad L, Schäfer P, Just S, Hofer HW, Malmsten M, et al. Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients. Atherosclerosis. 2007;192:438–44.PubMedCrossRef
110.
Luo Y. Alzheimer's disease, the nematode Caenorhabditis elegans, and Ginkgo biloba leaf extract. Life Sci. 2006;78:2066–72.PubMedCrossRef
111.
Park Y-M, Won J-H, Yun K-J, Ryu J-H, Han Y-N, Choi S-K, et al. Preventive effect of Ginkgo biloba extract (GBB) on the lipopolysaccharide-induced expressions of inducible nitric oxide synthase and cyclooxygenase-2 via suppression of nuclear factor-κB in RAW 264.7 cells. Biol Pharm Bull. 2006;29:985–90.PubMedCrossRef
112.
Biddlestone L, Corbett AD, Dolan S. Oral administration of Ginkgo biloba extract, EGb-761 inhibits thermal hyperalgesia in rodent models of inflammatory and post-surgical pain. Br J Pharmacol. 2007;151:285–91.PubMedPubMedCentralCrossRef
113.
Nada SE, Tulsulkar J, Shah ZA. Heme oxygenase 1-mediated neurogenesis is enhanced by Ginkgo biloba (EGb 761®) after permanent ischemic stroke in mice. Mol Neurobiol. 2014;49:945–56.PubMedCrossRef
114.
Tulsulkar J, Shah ZA. Ginkgo biloba prevents transient global ischemia-induced delayed hippocampal neuronal death through antioxidant and anti-inflammatory mechanism. Neurochem Int. 2013;62:189–97.PubMedCrossRef
115.
Chen J-S, Huang P-H, Wang C-H, Lin F-Y, Tsai H-Y, Wu T-C, et al. Nrf-2 mediated heme oxygenase-1 expression, an antioxidant-independent mechanism, contributes to anti-atherogenesis and vascular protective effects of Ginkgo biloba extract. Atherosclerosis. 2011;214:301–9.PubMedCrossRef
116.
Shah ZA, Nada SE, Doré S. Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Ginkgo biloba (EGb 761) neuroprotection. Neuroscience. 2011;180:248–55.PubMedPubMedCentralCrossRef
Metadata
Title
Comparative efficacy of Chinese herbal injections for treating acute cerebral infarction: a network meta-analysis of randomized controlled trials
Authors
Shi Liu
Jia-Rui Wu
Dan Zhang
Kai-Huan Wang
Bing Zhang
Xiao-Meng Zhang
Di Tan
Xiao-Jiao Duan
Ying-Ying Cui
Xin-Kui Liu
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2018
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-018-2178-9

Other articles of this Issue 1/2018

BMC Complementary Medicine and Therapies 1/2018 Go to the issue

Research article

Prevalence of and factors associated with utilization of herbal medicines among outpatients in primary health centers in Cambodia

Research article

Evaluation of biological potential of selected species of family Poaceae from Bahawalpur, Pakistan

Research article

Terminalia chebula extract prevents scopolamine-induced amnesia via cholinergic modulation and anti-oxidative effects in mice

Research article

Inhibition of lipopolysaccharide (LPS)-induced neuroinflammatory response by polysaccharide fractions of Khaya grandifoliola (C.D.C.) stem bark, Cryptolepis sanguinolenta (Lindl.) Schltr and Cymbopogon citratus Stapf leaves in raw 264.7 macrophages and U87 glioblastoma cells

Research article

Anti-aging potential of extracts from Sclerocarya birrea (A. Rich.) Hochst and its chemical profiling by UPLC-Q-TOF-MS

Research article

The genotoxicity of an aqueous extract of Gyejibokryeong-hwan